A rapid, inexpensive diagnostic for bacterial pathogen and resistance detection in resource-limited settings
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
To our knowledge, this represents the first demonstration of the CRISPR-Cas13a diagnostic platform on clinical bloodstream infections to date and supports BADLOCK’s potential as a practical and scalable solution for rapid pathogen and resistance gene detection in resource-constrained settings.
Appeared: Sunday, October 4. Science Advances. Peer-reviewed journal.